EQNR372.90-4.60%
DNB307.70+0.26%
MOWI201.20-1.57%
YARA424.80-2.97%
TEL135.00-0.15%
Brent$79.24-2.61%
DIREKTE · 17:12 UTC
Selskaper

Health Care — Alle selskaper

Full analysedekning av selskaper innen health care. Tilbake til oversikten for Health Care →
Full analysedekning 2997 companies · showing 2251–2400
Sorter etter
603987Shanghai Stock Exchange

Shanghai Kindly Enterprise Development Group Co Ltd

Medical Equipment, Supplies & Distribution
Kurs$7.92
Børsverdi
P/E
Omsetning$2,30 mrd.
Driftsresultat$310,7 mill.
FCF$190,8 mill.

Shanghai Kindly Enterprise Development Group Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.21, indicating a relatively low reliance on debt financing. The comp…

Dilution: Low · Liquidity: Medium
6615TPEx

6615.Two

Biotechnology & Medical Research
Kurs$32.75
Børsverdi
P/E
Omsetning$385,7 mill.
Driftsresultat-$33,7 mill.
FCF$18,1 mill.

6615.TWO maintains a strong liquidity position, with a current ratio of 3.33, indicating the company can cover its short-term liabilities more than three times over. The company holds TWD 90.6 mill…

Dilution: Low · Liquidity: Low
6847TPEx

6847.Two

Medical Equipment, Supplies & Distribution
Kurs$61.80
Børsverdi$879,4 mill.
P/E
Omsetning$82,3 mill.
Driftsresultat
FCF

The company maintains a strong liquidity position, with cash and equivalents amounting to TWD 60,428,000, which is a significant portion of its total assets. The debt-to-equity ratio of 0.31 indica…

Dilution: Low · Liquidity: Low
7774Tokyo Stock Exchange

Japan Tissue Engineering Co Ltd

Medical Equipment, Supplies & Distribution
Kurs¥595.00
Børsverdi
P/E
Omsetning¥2,18 mrd.
Driftsresultat-¥742,8 mill.
FCF-¥655,1 mill.

Japan Tissue Engineering Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to ¥3.25 billion, representing 57% of total assets. The company's liquidity FPT (free cash…

Dilution: Low · Liquidity: Low
7876TPEx

7876.Two

Biotechnology & Medical Research
Kurs$36.55
Børsverdi$3,91 mrd.
P/E
Omsetning$0,00
Driftsresultat-$339,8 mill.
FCF-$217,0 mill.

The company maintains a strong liquidity position, as evidenced by a current ratio of 18.3, indicating that it holds significantly more current assets than current liabilities. However, the company…

Dilution: Low · Liquidity: Medium
8406HKEX

China Oral Industry Group Holdings Ltd

Healthcare Facilities & Services
KursHK$0.05
BørsverdiHK$83,7 mill.
P/E
OmsetningHK$167,6 mill.
Driftsresultat-HK$43,1 mill.
FCF

The company's capital structure is characterized by a market price of 0.051 and a market cap of 83.71 million, with a price-to-book ratio of 0.87, indicating that the market value is below the book…

Dilution: Low · Liquidity: Medium
9627Tadawul

9627.Se

Healthcare Facilities & Services
Kurs$8.91
Børsverdi
P/E
Omsetning$183,1 mill.
Driftsresultat-$7,1 mill.
FCF-$27,8 mill.

The company's capital structure shows a debt-to-equity ratio of 0.69, indicating a moderate level of leverage. However, the company's liquidity position is characterized by a current ratio of 1.44,…

Dilution: Low · Liquidity: Medium
ACOGBursa Malaysia

Acog.Kl

Pharmaceuticals
Kurs$0.16
Børsverdi
P/E
Omsetning$141,0 mill.
Driftsresultat
FCF

ACOG.KL maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.11, indicating a low reliance on debt financing. The company's liquidity position is assessed as medi…

Dilution: Low · Liquidity: Medium
ALEMGEuronext Paris

Laboratoires Euromedis SA

Medical Equipment, Supplies & Distribution
Kurs€5.00
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

Laboratoires Euromedis SA has a basic and diluted share count of 2,844,222, indicating no dilution from stock options or convertible securities. The company's liquidity risk could not be assessed d…

Dilution: Low · Liquidity: Unknown
ALRTFOTC

ALR Technologies SG Ltd.

Medical Equipment & Supplies
Kurs$0.02
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

ALR Technologies SG Ltd. operates in the Medical Devices industry within the Healthcare Equipment & Supplies sector, though specific operational details and revenue sources are not disclosed in the…

Dilution: Unknown · Liquidity: Unknown
AYUPAASX

Ayupa.Ax

Healthcare Facilities & Services
KursA$62.61
BørsverdiA$481,7 mill.
P/E16,1
Omsetning
DriftsresultatA$188,2 mill.
FCF-A$6,7 mill.

AYUPA.AX has a market capitalization of $426.996 million and a price-to-earnings ratio of 16.08, indicating a moderate valuation relative to its earnings. The company's price-to-book ratio is 0.34,…

Dilution: Low · Liquidity: Medium
BDMDNASDAQ

Baird Medical Investment Holdings Ltd

Diversified Medical Equipment & Supplies
Kurs$1.09
Børsverdi$44,4 mill.
P/E
Omsetning$22,5 mill.
Driftsresultat-$25,6 mill.
FCF-$26,5 mill.

The company's capital structure shows a debt-to-equity ratio of 0.61, indicating a moderate level of leverage. However, the liquidity position is concerning, with negative net cash after subtractin…

Dilution: Low · Liquidity: Medium
BLISNSE (India)

Blis.Ns

Diversified Pharmaceuticals
Kurs$277.65
Børsverdi
P/E
Omsetning$8,10 mrd.
Driftsresultat$972,7 mill.
FCF$379,4 mill.

BLIS.NS maintains a strong liquidity position with a current ratio of 4.77, indicating that the company has sufficient short-term assets to cover its short-term liabilities. However, the company's…

Dilution: Low · Liquidity: Medium
BSNL.SJ

Bosnalijek dd Sarajevo

Pharmaceuticals
Kurs
Børsverdi
P/E
Omsetning$24,5 mill.
Driftsresultat-$4,7 mill.
FCF-$2,6 mill.

Bosnalijek dd Sarajevo has a liquidity risk score of medium, with a current ratio of 1.61 and negative free cash flow of -2.55 million BAM. The company holds 10.7 million BAM in cash and equivalent…

Dilution: Low · Liquidity: Medium
BTCASX

Btc.Ax

Biotechnology & Medical Research
KursA$0.05
Børsverdi
P/E
OmsetningA$10,0k
Driftsresultat-A$665,5k
FCFA$4,0 mill.

BTC.AX maintains a strong liquidity position with a current ratio of 3.16, indicating the company can easily cover its short-term liabilities with its current assets. The company has no long-term d…

Dilution: Low · Liquidity: Low
CICO

Consultant and Investment Group Company Psc

Healthcare Facilities & Services
Kurs$1.78
Børsverdi
P/E
Omsetning$4,9 mill.
Driftsresultat$249,0k
FCF-$287,5k

The company maintains a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. However, its liquidity position is constrained, with a current ratio of 1.06, suggesting limi…

Dilution: Low · Liquidity: Medium
DSOL.PKOTC

Drug Free Solution Inc

Healthcare Facilities & Services
Kurs$0.00
Børsverdi
P/E
Omsetning
Driftsresultat-$17,2k
FCF

Drug Free Solution Inc has a capital structure characterized by a total equity of $20,030,000 and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's liquidity position is…

Dilution: Low · Liquidity: Low
EMBRSGX

Embr.Si

Advanced Medical Equipment & Technology
Kurs$0.05
Børsverdi
P/E
Omsetning$5,3 mill.
Driftsresultat-$3,9 mill.
FCF-$3,7 mill.

Embre's capital structure is characterized by a debt-to-equity ratio of 1.58, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a curren…

Dilution: Low · Liquidity: Medium
FIT

Fit.Hm

Pharmaceuticals
Kurs$4100.00
Børsverdi$1,39 bill.
P/E0,0
Omsetning$2,07 bill.
Driftsresultat$109,87 mrd.
FCF-$50,46 mrd.

FIT.HM maintains a capital structure with a debt-to-equity ratio of 0.43, indicating a relatively balanced mix of debt and equity financing. The company's liquidity position is characterized as med…

Dilution: Low · Liquidity: Medium
FREDBSE (India)

Fredun Pharmaceuticals Ltd

Pharmaceuticals
Kurs$2361.00
Børsverdi
P/E
Omsetning$4,54 mrd.
Driftsresultat$475,3 mill.
FCF$186,7 mill.

FRED.BO's capital structure is characterized by a debt-to-equity ratio of 1.19, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a curr…

Dilution: Low · Liquidity: Medium
GIPL.PKOTC

Global Innovative Platforms Inc

Advanced Medical Equipment & Technology
Kurs$0.45
Børsverdi
P/E
Omsetning$0,00
Driftsresultat-$3,9k
FCF

The company's capital structure is highly leveraged, with total liabilities of $201,000 million and total equity of -$200,400 million, resulting in a debt-to-equity ratio of -0.94. The company has…

Dilution: Low · Liquidity: Medium
HANNBSE (India)

Hann.Bo

Healthcare Facilities & Services
Kurs$75.00
Børsverdi
P/E
Omsetning$775,3 mill.
Driftsresultat$134,5 mill.
FCF$23,2 mill.

HANN.BO maintains a capital structure with a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a curr…

Dilution: Low · Liquidity: Medium
HENWarsaw Stock Exchange

Hen.Wa

Biotechnology & Medical Research
Kurs$2.32
Børsverdi
P/E
Omsetning$3,3 mill.
Driftsresultat$1,6 mill.
FCF$50,3k

HEN.WA maintains a conservative capital structure with a low debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing. The company's liquidity position is characterized as medium…

Dilution: Low · Liquidity: Medium
ICONasdaq Stockholm

Iconovo AB

Medical Equipment, Supplies & Distribution
Kurs$0.96
Børsverdi$92,7 mill.
P/E
Omsetning$1,1 mill.
Driftsresultat-$43,1 mill.
FCF-$47,8 mill.

Iconovo AB's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a current rat…

Dilution: Low · Liquidity: Medium
ICOIBursa Malaysia

Iconic Worldwide Bhd

Medical Equipment, Supplies & Distribution
Kurs$0.07
Børsverdi
P/E
Omsetning$14,9 mill.
Driftsresultat-$3,8 mill.
FCF-$4,0 mill.

Iconic Worldwide Bhd has a debt-to-equity ratio of 0.62, indicating a moderate level of leverage, and a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company's free ca…

Dilution: Low · Liquidity: Medium
IDXG.PKOTC

Idxg.Pk

Pharmaceutical Services
Kurs$1.55
Børsverdi
P/E
Omsetning$38,7 mill.
Driftsresultat$4,1 mill.
FCF$25,1 mill.

IDXG maintains a strong liquidity position, with a current ratio of 1.94, indicating the company can cover its short-term liabilities with its short-term assets. The company has no long-term debt,…

Dilution: Low · Liquidity: Low
METOBursa Malaysia

Metro Healthcare Bhd

Healthcare Facilities & Services
Kurs$0.22
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

Metro Healthcare Bhd has a basic and diluted share count of 978,905,000 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. Howev…

Dilution: Low · Liquidity: Unknown
MIDAN.KW

Al-Maidan Clinic for Oral Health Services Company KSCP

Healthcare Facilities & Services
Kurs$820.00
Børsverdi
P/E
Omsetning$72,0 mill.
Driftsresultat$13,9 mill.
FCF$8,6 mill.

The company maintains a strong liquidity position, with a current ratio of 2.7, indicating that it has 2.7 times more current assets than current liabilities. Its cash and equivalents amount to KWD…

Dilution: Low · Liquidity: Low
MPCI

Mpci.Ca

Pharmaceuticals
Kurs$217.05
Børsverdi$4,94 mrd.
P/E4,2
Omsetning$1,51 mrd.
Driftsresultat$529,3 mill.
FCF$474,7 mill.

MPCI.CA maintains a strong liquidity position, with a current ratio of 2.15 and a significant cash and equivalents balance of $678.6 million. The company's price-to-book ratio of 2.76 and price-to-…

Dilution: Low · Liquidity: Low
MPHTSX Venture

Mph.V

Biotechnology & Medical Research
KursC$1.07
BørsverdiC$11,2 mill.
P/E
OmsetningC$28,9 mill.
Driftsresultat-C$6,9 mill.
FCF-C$4,5 mill.

MPH.V's capital structure is characterized by a low debt-to-equity ratio of 0.07, indicating a conservative leverage position. The company's liquidity is assessed as low, with a current ratio of 1.…

Dilution: Low · Liquidity: Low
NISATASE (Tel Aviv)

Nisa.Ta

Medical Equipment, Supplies & Distribution
Kurs$730.20
Børsverdi
P/E
Omsetning$651,8 mill.
Driftsresultat$23,1 mill.
FCF-$6,2 mill.

NISA.TA's capital structure is characterized by a debt-to-equity ratio of 0.98, indicating a relatively balanced mix of debt and equity financing. The company's liquidity position is assessed as me…

Dilution: Low · Liquidity: Medium
NUTMSET (Bangkok)

Nutrition Profess PCL

Pharmaceuticals
Kurs
Børsverdi
P/E
Omsetning$300,2 mill.
Driftsresultat$25,7 mill.
FCF$29,9 mill.

Nutrition Profess PCL maintains a capital structure with 120 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure from share-based compensation or convertib…

Dilution: Low · Liquidity: Unknown
NXII.MZ

Numeral Ltd

Biotechnology & Medical Research
Kurs$0.06
Børsverdi
P/E
Omsetning$83,0k
Driftsresultat$102,3k
FCF

Numeral Ltd exhibits a highly leveraged capital structure, with total liabilities of $179,270 million and total equity of -$146,960 million, resulting in a negative debt-to-equity ratio of -0.71. T…

Dilution: Low · Liquidity: Medium
OTLC.PKOTC

Oncotelic Therapeutics Inc

Pharmaceuticals & Medical Research
Kurs$0.04
Børsverdi
P/E
Omsetning
Driftsresultat-$255,5k
FCF

Oncotelic Therapeutics Inc exhibits a capital structure with a debt-to-equity ratio of 1.09, indicating a moderate reliance on debt financing. The company's liquidity position is weak, as evidenced…

Dilution: Low · Liquidity: Medium
OUEESGX

OUE Healthcare Ltd

Healthcare Facilities & Services
Kurs$0.03
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

OUE Healthcare Ltd has a basic and diluted share count of 4.44 billion shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. Howeve…

Dilution: Low · Liquidity: Unknown
PFHO.PKOTC

Pfho.Pk

Healthcare Providers & Services
Kurs$0.80
Børsverdi
P/E
Omsetning$6,7 mill.
Driftsresultat$1,0 mill.
FCF$1,4 mill.

PFHO.PK maintains a strong liquidity position, as evidenced by a current ratio of 34.45, indicating a significant buffer of current assets over current liabilities. The company has no long-term deb…

Dilution: Low · Liquidity: Low
PREVBSE (India)

Prev.Bo

Advanced Medical Equipment & Technology
Kurs$404.10
Børsverdi
P/E
Omsetning$630,3 mill.
Driftsresultat$201,8 mill.
FCF$168,9 mill.

The company maintains a strong liquidity position, with a current ratio of 14.38, indicating a significant buffer of current assets over current liabilities. It holds INR 109.42 million in cash and…

Dilution: Low · Liquidity: Low
PRKMNSE (India)

Park Medi World Ltd

Healthcare Facilities & Services
Kurs$287.28
Børsverdi
P/E
Omsetning$13,94 mrd.
Driftsresultat$3,19 mrd.
FCF$1,13 mrd.

Park Medi World Ltd maintains a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a cur…

Dilution: Low · Liquidity: Medium
PRVABSE (India)

Prva.Bo

Healthcare Providers & Services
Kurs$7.17
Børsverdi
P/E
Omsetning$535,7 mill.
Driftsresultat$27,8 mill.
FCF$46,4 mill.

PRVA.BO has a debt-to-equity ratio of 0.24, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is characterized as medium risk, with a cu…

Dilution: Low · Liquidity: Medium
RDGWarsaw Stock Exchange

Read Gene SA

Biotechnology & Medical Research
Kurs$4.98
Børsverdi
P/E
Omsetning$2,1 mill.
Driftsresultat-$543,2k
FCF-$390,3k

Read Gene SA has a current ratio of 10.28, indicating strong liquidity with current assets significantly outpacing current liabilities. The company has no long-term debt, and its debt-to-equity rat…

Dilution: Low · Liquidity: Low
REKATASE (Tel Aviv)

Rekah Pharmaceutical Industry Ltd

Pharmaceuticals
Kurs$1065.00
Børsverdi
P/E
Omsetning$89,7 mill.
Driftsresultat$2,8 mill.
FCF$6,2 mill.

Rekah's capital structure is characterized by a debt-to-equity ratio of 1.11, indicating a moderate reliance on debt financing. The company holds cash and equivalents of 11,039,000 ILS, but its lon…

Dilution: Low · Liquidity: Medium
RPHSET (Bangkok)

Rph.Bk

Healthcare Facilities & Services
Kurs$4.88
Børsverdi
P/E
Omsetning$1,16 mrd.
Driftsresultat$231,5 mill.
FCF$28,1 mill.

RPH.BK maintains a strong liquidity position, with a current ratio of 3.63, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity is suppor…

Dilution: Low · Liquidity: Medium
RYOJNASDAQ

rYojbaba Co Ltd

Healthcare Providers & Services
Kurs$5.20
Børsverdi$60,1 mill.
P/E327,0
Omsetning$9,3 mill.
Driftsresultat-$755,4k
FCF$677,0k

RYojbaba Co Ltd maintains a strong liquidity position, with $6.16 million in cash and equivalents, representing 36.4% of total assets. The company's liquidity FPT (free cash flow to total liabiliti…

Dilution: Low · Liquidity: Low
TAKENSE (India)

Take.Ns

Biotechnology & Medical Research
Kurs$25.60
Børsverdi
P/E
Omsetning$0,00
Driftsresultat-$74,7 mill.
FCF$7,4 mill.

TAKE.NS has a strong liquidity position, as evidenced by its current ratio of 1.48, indicating that it has sufficient current assets to cover its current liabilities. The company's cash and equival…

Dilution: Low · Liquidity: Low
TNHMSET (Bangkok)

Thai Nakarin Hospital PCL

Healthcare Facilities & Services
Kurs
Børsverdi
P/E
Omsetning$2,77 mrd.
Driftsresultat$465,7 mill.
FCF$176,3 mill.

Thai Nakarin Hospital PCL maintains a strong capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative approach to leverage. The company's liquidity is r…

Dilution: Low · Liquidity: Low
VASO.PKOTC

Vaso.Pk

Advanced Medical Equipment & Technology
Kurs$0.26
Børsverdi
P/E
Omsetning$89,1 mill.
Driftsresultat-$2,1 mill.
FCF$1,5 mill.

VASO.PK maintains a strong liquidity position, with $35.05 million in cash and equivalents, representing 39.67% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is…

Dilution: Low · Liquidity: Low
VICP.PKOTC

Vicapsys Life Sciences Inc

Biotechnology & Medical Research
Kurs$1.45
Børsverdi
P/E
Omsetning$0,00
Driftsresultat-$492,6k
FCF-$484,8k

Vicapsys Life Sciences Inc exhibits a highly leveraged capital structure, with total liabilities of $1,022,810 and total equity of -$950,790, indicating a negative net worth. The company's liquidit…

Dilution: Low · Liquidity: Low
VICPSGX

Vicp.Si

Medical Equipment, Supplies & Distribution
Kurs$0.09
Børsverdi
P/E
Omsetning$115,8 mill.
Driftsresultat$93,0k
FCF-$1,0 mill.

The company's capital structure shows a debt-to-equity ratio of 0.58, indicating a moderate level of leverage. However, its liquidity position is assessed as medium, with a current ratio of 1.46, s…

Dilution: Low · Liquidity: Medium
XINTNasdaq Stockholm

Xintela AB

Biotechnology & Medical Research
Kurs$0.18
Børsverdi$155,9 mill.
P/E
Omsetning$2,3 mill.
Driftsresultat-$46,7 mill.
FCF-$48,0 mill.

Xintela AB operates with a negative equity position of -5.27 million SEK and a cash and equivalents balance of 23.21 million SEK, indicating a liquidity cushion despite a negative net income of -48…

Dilution: Low · Liquidity: Low
002566Shenzhen Stock Exchange

002566.Sz

Pharmaceuticals
Kurs$17.69
Børsverdi$5,85 mrd.
P/E83,8
Omsetning$640,2 mill.
Driftsresultat$31,0 mill.
FCF$12,4 mill.

The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.2, indicating a low reliance on debt financing. Its liquidity position is characterized as medium, wi…

Dilution: Low · Liquidity: Medium
041960KOSDAQ

Komipharm International Co Ltd

Pharmaceuticals
Kurs$7600.00
Børsverdi$546,50 mrd.
P/E
Omsetning$52,47 mrd.
Driftsresultat$634,0 mill.
FCF-$9,66 mrd.

Komipharm has a market price of 7,600 KRW and a market capitalization of 546.5 billion KRW, with a price-to-book ratio of 7.86 and a price-to-tangible-book ratio of 7.86. The company's enterprise v…

Dilution: Low · Liquidity: Medium
046210KOSDAQ

046210.Kq

Biotechnology & Medical Research
Kurs$1480.00
Børsverdi
P/E
Omsetning$15,05 mrd.
Driftsresultat-$7,85 mrd.
FCF-$3,34 mrd.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.22, indicating a relatively conservative approach to financing. The company maintains a strong liquidity position…

Dilution: Low · Liquidity: Low
066700KOSDAQ

066700.Kq

Pharmaceuticals
Kurs$2340.00
Børsverdi
P/E
Omsetning$271,59 mrd.
Driftsresultat$10,17 mrd.
FCF$15,55 mrd.

The company maintains a relatively strong liquidity position, with a current ratio of 1.95, indicating that it has sufficient current assets to cover its current liabilities. However, the liquidity…

Dilution: Low · Liquidity: Medium
067080KOSDAQ

Dae Hwa Pharm Co Ltd

Pharmaceuticals
Kurs$13480.00
Børsverdi$241,31 mrd.
P/E145,9
Omsetning$143,06 mrd.
Driftsresultat$7,54 mrd.
FCF$1,07 mrd.

Dae Hwa Pharm Co Ltd has a market capitalization of KRW 241.31 billion and a price-to-earnings ratio of 145.94, indicating a high valuation relative to its earnings. The company's price-to-book rat…

Dilution: Low · Liquidity: Medium
115450KOSDAQ

HLB Therapeutics Co Ltd

Pharmaceuticals
Kurs$2910.00
Børsverdi
P/E
Omsetning$69,56 mrd.
Driftsresultat-$6,97 mrd.
FCF-$15,11 mrd.

HLB Therapeutics has a current liquidity position that is medium, with a cash and equivalents balance of KRW 20.31 billion and a negative free cash flow of KRW -15.11 billion. The company's debt-to…

Dilution: Low · Liquidity: Medium
140410KOSDAQ

Mezzion Pharma Co Ltd

Pharmaceuticals
Kurs$73900.00
Børsverdi
P/E
Omsetning$7,91 mrd.
Driftsresultat-$16,84 mrd.
FCF-$47,21 mrd.

Mezzion Pharma Co Ltd operates with a capital structure that includes significant cash and equivalents of KRW 25,573,447,000, which is partially offset by a high level of long-term debt of KRW 11,8…

Dilution: Low · Liquidity: Low
153710KOSDAQ

OptiPharm Co Ltd

Pharmaceuticals
Kurs$4630.00
Børsverdi$67,92 mrd.
P/E
Omsetning$22,34 mrd.
Driftsresultat-$2,41 mrd.
FCF-$3,37 mrd.

OptiPharm's capital structure shows a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position compared to the industry median of 0.65. The company maintains a current r…

Dilution: Low · Liquidity: Medium
1541HKEX

1541.Hk

Biotechnology & Medical Research
KursHK$3.76
Børsverdi
P/E
OmsetningHK$154,3 mill.
Driftsresultat-HK$214,0 mill.
FCF

The company maintains a strong liquidity position, with a current ratio of 3.83, indicating that it has sufficient short-term assets to cover its short-term liabilities. Its cash and equivalents am…

Dilution: Low · Liquidity: Low
166480KOSDAQ

166480.Kq

Biotechnology & Medical Research
Kurs$3500.00
Børsverdi
P/E
Omsetning$20,16 mrd.
Driftsresultat-$26,53 mrd.
FCF-$24,73 mrd.

The company's capital structure is characterized by a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. However, the company's liquidity position is weak, as evidenced…

Dilution: Low · Liquidity: Medium
2170HKEX

2170.Hk

Healthcare Facilities & Services
KursHK$1.41
BørsverdiHK$385,7 mill.
P/E
OmsetningHK$233,3 mill.
Driftsresultat-HK$214,1 mill.
FCF

The company's capital structure is characterized by a low debt-to-equity ratio of 0.37, indicating a relatively conservative approach to financing. The liquidity position is strong, as evidenced by…

Dilution: Low · Liquidity: Low
229500.KN

229500.Kn

Biotechnology & Medical Research
Kurs$8800.00
Børsverdi
P/E
Omsetning$34,8 mill.
Driftsresultat-$5,37 mrd.
FCF-$10,24 mrd.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.04, indicating a conservative approach to leverage. With total equity of 3,592,612,440 KRW and total liabilities…

Dilution: Low · Liquidity: Low
261200KOSDAQ

Dentis Co Ltd

Medical Equipment, Supplies & Distribution
Kurs$2615.00
Børsverdi$41,34 mrd.
P/E16,3
Omsetning$28,57 mrd.
Driftsresultat$1,42 mrd.
FCF-$5,05 mrd.

Dentis Co Ltd maintains a debt-to-equity ratio of 1.41, indicating a moderate reliance on debt financing, and a current ratio of 0.93, suggesting limited short-term liquidity. The company's price-t…

Dilution: Low · Liquidity: Medium
2677HKEX

2677.Hk

Healthcare Facilities & Services
KursHK$24.48
BørsverdiHK$1,58 mrd.
P/E10,9
OmsetningHK$1,06 mrd.
DriftsresultatHK$27,8 mill.
FCFHK$215,5 mill.

The company's capital structure is characterized by a negative total equity of CNY -1,635,993,000 and a high long-term debt of CNY 2,550,268,000, indicating a significant reliance on debt financing…

Dilution: Low · Liquidity: Medium
2898HKEX

2898.Hk

Biotechnology & Medical Research
KursHK$6.39
Børsverdi
P/E
Omsetning
Driftsresultat-HK$79,0 mill.
FCF-HK$119,8 mill.

The company maintains a strong liquidity position, with a current ratio of 11.17, indicating that it has significantly more current assets than current liabilities. However, the company reported ne…

Dilution: Low · Liquidity: Low
300254Shenzhen Stock Exchange

Shanxi C&Y Pharmaceutical Group Co Ltd

Pharmaceuticals
Kurs$11.87
Børsverdi
P/E
Omsetning$870,8 mill.
Driftsresultat$79,3 mill.
FCF$57,4 mill.

Shanxi C&Y Pharmaceutical Group Co Ltd has a debt-to-equity ratio of 2.31, indicating a capital structure that is heavily leveraged relative to equity. The company's liquidity is assessed as medium…

Dilution: Low · Liquidity: Medium
300937Shenzhen Stock Exchange

Sichuan Hz-yeg Medical Co Ltd

Pharmaceuticals
Kurs$24.76
Børsverdi
P/E
Omsetning$4,45 mrd.
Driftsresultat
FCF

SICHUAN HZ-YEG MEDICAL Co Ltd has a debt-to-equity ratio of 0.41, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity is assessed as me…

Dilution: Low · Liquidity: Medium
307750KOSDAQ

Kukjeon Co Ltd

Pharmaceuticals
Kurs$3500.00
Børsverdi
P/E
Omsetning$39,31 mrd.
Driftsresultat$1,61 mrd.
FCF-$5,36 mrd.

Kukjeon Co Ltd maintains a debt-to-equity ratio of 0.8, indicating a relatively balanced capital structure, though it is leveraged with long-term debt of KRW 77,953,490,890. The company's liquidity…

Dilution: Low · Liquidity: Medium
322510KOSDAQ

322510.Kq

Advanced Medical Equipment & Technology
Kurs$5870.00
Børsverdi$148,86 mrd.
P/E
Omsetning$3,34 mrd.
Driftsresultat-$13,20 mrd.
FCF-$13,28 mrd.

The company's capital structure is characterized by a debt-to-equity ratio of 0.73, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…

Dilution: Low · Liquidity: Medium
366ATokyo Stock Exchange

366a.T

Healthcare Facilities & Services
Kurs¥1076.00
Børsverdi¥13,41 mrd.
P/E17,7
Omsetning¥14,06 mrd.
Driftsresultat¥1,11 mrd.
FCF¥762,7 mill.

366A.T maintains a strong liquidity position, with cash and equivalents amounting to ¥2.79 billion, representing a significant portion of its total assets of ¥5.18 billion. The company's liquidity…

Dilution: Low · Liquidity: Low
377740KRX

377740.Ks

Pharmaceuticals
Kurs₩4520.00
Børsverdi
P/E
Omsetning₩118,32 mrd.
Driftsresultat₩16,70 mrd.
FCF-₩106,81 mrd.

The company's capital structure is characterized by a very low debt-to-equity ratio of 0.0, indicating a strong equity position relative to liabilities. However, the company's liquidity position is…

Dilution: Low · Liquidity: Medium
4130TPEx

Genovate Biotechnology Co Ltd

Pharmaceuticals
Kurs$27.65
Børsverdi$3,78 mrd.
P/E212,1
Omsetning$139,4 mill.
Driftsresultat$19,1 mill.
FCF$16,4 mill.

Genovate maintains a strong liquidity position, with a current ratio of 5.86 and cash and equivalents of TWD 158.19 million, which is significantly higher than the industry median. The company's li…

Dilution: Low · Liquidity: Low
4150TPEx

4150.Two

Medical Equipment, Supplies & Distribution
Kurs$5.95
Børsverdi
P/E
Omsetning$641,1 mill.
Driftsresultat-$241,1 mill.
FCF-$272,7 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 0.8, indicating a moderate level of leverage. However, the liquidity position is concerning, as the company has negativ…

Dilution: Low · Liquidity: Medium
450330KOSDAQ

Hass Corp

Medical Equipment, Supplies & Distribution
Kurs$5170.00
Børsverdi
P/E
Omsetning$4,33 mrd.
Driftsresultat$748,5 mill.
FCF$583,9 mill.

Hass Corp maintains a capital structure with a debt-to-equity ratio of 0.75, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio o…

Dilution: Low · Liquidity: Medium
4512Tokyo Stock Exchange

4512.T

Pharmaceuticals
Kurs¥246.00
Børsverdi
P/E
Omsetning¥7,79 mrd.
Driftsresultat-¥461,3 mill.
FCF-¥84,1 mill.

The company maintains a strong liquidity position, with a current ratio of 4.38, indicating that it has more than four times as many current assets as current liabilities. Its cash and equivalents…

Dilution: Low · Liquidity: Low
6078Tokyo Stock Exchange

Value HR Co Ltd

Healthcare Facilities & Services
Kurs¥1389.00
Børsverdi
P/E
Omsetning¥10,07 mrd.
Driftsresultat¥832,0 mill.
FCF-¥420,9 mill.

Value HR Co Ltd maintains a liquidity position with a current ratio of 1.02, indicating a balanced short-term liquidity profile, though its free cash flow is negative at -420.91 million JPY, sugges…

Dilution: Low · Liquidity: Medium
6621TPEx

6621.Two

Advanced Medical Equipment & Technology
Kurs$11.95
Børsverdi
P/E
Omsetning$88,4 mill.
Driftsresultat-$44,1 mill.
FCF-$35,4 mill.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.05, indicating a conservative leverage position. It maintains a strong liquidity position with a current ratio of…

Dilution: Low · Liquidity: Low
6676TPEx

6676.Two

Pharmaceuticals
Kurs$14.05
Børsverdi$2,09 mrd.
P/E
Omsetning$253,0 mill.
Driftsresultat
FCF

6676.TWO has a market capitalization of TWD 20.61 billion and an enterprise value to revenue ratio of 9.79, indicating a moderate valuation relative to its revenue. The company's liquidity position…

Dilution: Low · Liquidity: Medium
6767TPEx

6767.Two

Medical Equipment, Supplies & Distribution
Kurs$26.95
Børsverdi$1,06 mrd.
P/E
Omsetning$311,8 mill.
Driftsresultat-$28,4 mill.
FCF-$8,0 mill.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.14, indicating a conservative leverage position. Its liquidity is strong, with a current ratio of 8.57, supported…

Dilution: Low · Liquidity: Low
6893HKEX

Hin Sang Group (International) Holding Co Ltd

Pharmaceuticals
KursHK$0.22
BørsverdiHK$242,4 mill.
P/E
Omsetning
Driftsresultat
FCF

Hin Sang Group has a market capitalization of HKD 294.8 million, with a market price of HKD 0.27 per share, based on the latest available data. The company has no dilution risk in the near term, as…

Dilution: Low · Liquidity: Unknown
93M1KXetra

MPH Health Care AG

Pharmaceuticals
Kurs
Børsverdi
P/E
Omsetning€30,2k
Driftsresultat€33,0 mill.
FCF€32,1 mill.

The company maintains a strong capital structure, with a debt-to-equity ratio of 0.04, indicating a low reliance on debt financing. Its liquidity position is characterized as medium, with a current…

Dilution: Low · Liquidity: Medium
AAQ1KXetra

Aap Implantate AG

Medical Equipment, Supplies & Distribution
Kurs
Børsverdi
P/E
Omsetning€3,0 mill.
Driftsresultat
FCF

Aap Implantate AG has 13,907,656 basic and diluted shares outstanding, with no dilution risk currently identified. However, liquidity risk could not be assessed due to the absence of balance-sheet…

Dilution: Low · Liquidity: Unknown
AAYUBSE (India)

Aayu.Bo

Pharmaceuticals
Kurs$33.08
Børsverdi
P/E
Omsetning$733,5 mill.
Driftsresultat$33,4 mill.
FCF$33,0 mill.

AAYU.BO exhibits a strong capital structure with a debt-to-equity ratio of 0.01, indicating minimal leverage and a conservative approach to financing. The company's liquidity position is characteri…

Dilution: Low · Liquidity: Medium
AERG.PKOTC

Aerg.Pk

Healthcare Equipment
Kurs$1.27
Børsverdi
P/E
Omsetning$461,7k
Driftsresultat-$14,9 mill.
FCF-$15,6 mill.

The company's capital structure is characterized by a very low debt-to-equity ratio of 0.01, indicating a strong reliance on equity financing and minimal leverage. With $6.44 million in cash and eq…

Dilution: Low · Liquidity: Low
ALBIOEuronext Paris

Biosynex

Medical Equipment, Supplies & Distribution
Kurs€0.91
Børsverdi
P/E
Omsetning€101,2 mill.
Driftsresultat-€37,9 mill.
FCF-€26,6 mill.

The company's capital structure is marked by a debt-to-equity ratio of 0.77, indicating a moderate reliance on debt financing. However, its liquidity position is weak, as evidenced by a current rat…

Dilution: Low · Liquidity: Medium
ALECREuronext Paris

Eurofins Cerep

Biotechnology & Medical Research
Kurs€16300.00
Børsverdi
P/E
Omsetning€40,5 mill.
Driftsresultat€4,8 mill.
FCF

ALECR.PA maintains a strong liquidity position with a current ratio of 6.85, indicating the company can easily cover its short-term liabilities with its current assets. The company's capital struct…

Dilution: Low · Liquidity: Medium
ALLASGX

Alla.Si

Healthcare Facilities & Services
Kurs$0.15
Børsverdi
P/E
Omsetning$77,1 mill.
Driftsresultat$2,0 mill.
FCF$5,2 mill.

Alla Therapeutics maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.73, indicating moderate leverage. The company holds $16.4 million in cash and equivalents, but…

Dilution: Low · Liquidity: Medium
BJP.PL

Beit Jala Pharmaceutical Manufacturing Co

Pharmaceuticals
Kurs$3.62
Børsverdi
P/E
Omsetning$2,3 mill.
Driftsresultat$423,5k
FCF$508,2k

Beit Jala Pharmaceutical Manufacturing Co maintains a strong liquidity position, with a current ratio of 4.32, indicating that it has more than four times the current assets to cover its current li…

Dilution: Low · Liquidity: Low
BLCSET (Bangkok)

Blc.Bk

Pharmaceuticals
Kurs$3.90
Børsverdi
P/E
Omsetning$1,67 mrd.
Driftsresultat$228,8 mill.
FCF-$559,9 mill.

BLC.BK maintains a relatively strong liquidity position, with a current ratio of 2.01, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's…

Dilution: Low · Liquidity: Medium
BROONSE (India)

Broo.Ns

Pharmaceuticals
Kurs$46.61
Børsverdi
P/E
Omsetning$825,6 mill.
Driftsresultat$34,3 mill.
FCF-$92,9 mill.

BROO.NS has a current ratio of 1.48, indicating moderate liquidity, and a debt-to-equity ratio of 0.08, suggesting a relatively low reliance on debt financing. However, the company's free cash flow…

Dilution: Low · Liquidity: Medium
CIZLondon Stock Exchange

Cizzle Biotechnology Holdings PLC

Biotechnology & Medical Research
Kurs$2.95
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

Cizzle Biotechnology's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source do…

Dilution: Low · Liquidity: Unknown
CORTSX Venture

Camino Minerals Corp

Diversified Pharmaceuticals
KursC$0.51
Børsverdi
P/E
Omsetning
Driftsresultat-C$825,0k
FCF-C$742,5k

Camino Minerals Corp maintains a strong liquidity position with CAD 1,092,480 in cash and equivalents, supported by a current ratio of 1.24, indicating the company can cover its short-term liabilit…

Dilution: Low · Liquidity: Low
CVBASX

Cvb.Ax

Advanced Medical Equipment & Technology
KursA$0.04
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

CVB.AX has a basic and diluted share count of 477,734,297, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of balance…

Dilution: Low · Liquidity: Unknown
DGNSIDX (Jakarta)

Diagnos Laboratorium Utama PT Tbk

Healthcare Facilities & Services
Kurs$252.00
Børsverdi
P/E
Omsetning$39,30 mrd.
Driftsresultat-$168,9 mill.
FCF-$507,0 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 0.35, indicating a relatively conservative leverage position. However, the free cash flow is negative at -507,019,330 I…

Dilution: Low · Liquidity: Medium
DMC

Dmc.Hm

Pharmaceuticals
Kurs$57000.00
Børsverdi
P/E
Omsetning$2,07 bill.
Driftsresultat$244,38 mrd.
FCF$94,24 mrd.

DMC.HM maintains a strong capital structure with a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is robust, with a current ratio of 7.47, s…

Dilution: Low · Liquidity: Low
DTC.CD

Dtc.Cd

Biotechnology & Medical Research
Kurs$0.50
Børsverdi
P/E
Omsetning
Driftsresultat-$3,2 mill.
FCF-$3,4 mill.

DTC.CD's capital structure is highly leveraged, with total liabilities of CAD 29.1 million and total equity of CAD -12.6 million, resulting in a debt-to-equity ratio of -1.2. The company's liquidit…

Dilution: Low · Liquidity: Medium
EFIT.MU

EasyMotionSkin Tec GmbH

Advanced Medical Equipment & Technology
Kurs$1.15
Børsverdi
P/E
Omsetning
Driftsresultat
FCF

EasyMotionSkin Tec GmbH has a fully diluted share count of 29.2 million shares, matching its basic share count, indicating no dilution from stock options or convertible securities. However, liquidi…

Dilution: Low · Liquidity: Unknown
ENPASX

Enp.Ax

Biotechnology & Medical Research
KursA$0.03
Børsverdi
P/E
OmsetningA$1,6 mill.
Driftsresultat-A$5,3 mill.
FCF-A$5,4 mill.

ENP.AX maintains a strong liquidity position with a current ratio of 9.08, indicating that its current assets significantly exceed its current liabilities. The company holds $3,026,250 in cash and…

Dilution: Low · Liquidity: Low
GAUDNSE (India)

Gaud.Ns

Healthcare Facilities & Services
Kurs$107.83
Børsverdi
P/E
Omsetning$707,2 mill.
Driftsresultat$265,8 mill.
FCF$123,0 mill.

GAUD.NS maintains a relatively strong liquidity position, with a current ratio of 1.42, indicating that it has sufficient current assets to cover its current liabilities. However, the company's liq…

Dilution: Low · Liquidity: Medium
GTHP.PKOTC

Gthp.Pk

Advanced Medical Equipment & Technology
Kurs$0.28
Børsverdi
P/E
Omsetning$767,0k
Driftsresultat-$2,8 mill.
FCF-$3,3 mill.

GTHP.PK exhibits a highly leveraged capital structure, with total liabilities of $7.33 million and total equity of -$6.01 million, resulting in a negative debt-to-equity ratio of -0.37. The company…

Dilution: Low · Liquidity: Medium
IBNH

Ibnh.Am

Healthcare Facilities & Services
Kurs$0.86
Børsverdi
P/E
Omsetning$12,1 mill.
Driftsresultat$379,4k
FCF-$840,1k

IBNH.AM's capital structure is characterized by a debt-to-equity ratio of 0.77, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a curr…

Dilution: Low · Liquidity: Medium
IMMLondon Stock Exchange

ImmuPharma PLC

Biotechnology & Medical Research
Kurs$3.90
Børsverdi
P/E
Omsetning
Driftsresultat
FCF
Dilution: Low · Liquidity: Unknown
INIFYOslo Børs

INIFY Laboratories AB

Advanced Medical Equipment & Technology
Kurskr 8.00
Børsverdikr 859,8 mill.
P/E
Omsetningkr 3,6 mill.
Driftsresultat-kr 14,1 mill.
FCF

INIFY Laboratories AB operates with a market capitalization of SEK 425.6 million and a price-to-book ratio of 7.15, indicating a premium valuation relative to its book value. The company has no lon…

Dilution: Low · Liquidity: Low
JVC

Jvc.Hm

Advanced Medical Equipment & Technology
Kurs$3900.00
Børsverdi
P/E
Omsetning$763,15 mrd.
Driftsresultat$50,77 mrd.
FCF$32,83 mrd.

JVC.HM maintains a debt-to-equity ratio of 0.51, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidity position is characterized as…

Dilution: Low · Liquidity: Medium
KEAYBSE (India)

Keay.Bo

Healthcare Facilities & Services
Kurs$206.25
Børsverdi
P/E
Omsetning$1,20 mrd.
Driftsresultat-$99,7 mill.
FCF-$223,1 mill.

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 7.44, indicating a significant reliance on debt financing. Despite a current ratio of 0.46, which suggests limite…

Dilution: Low · Liquidity: Medium
KRMYNSE (India)

KRM Ayurveda Ltd

Healthcare Facilities & Services
Kurs$241.95
Børsverdi
P/E
Omsetning$765,5 mill.
Driftsresultat$180,7 mill.
FCF$84,2 mill.

KRM Ayurveda operates with a debt-to-equity ratio of 1.31, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.66, su…

Dilution: Low · Liquidity: Medium
MODDBSE (India)

Modern Diagnostic & Research Centre Ltd

Healthcare Facilities & Services
Kurs$57.39
Børsverdi
P/E
Omsetning$779,5 mill.
Driftsresultat$137,7 mill.
FCF-$14,0k

Modern Diagnostic & Research Centre Ltd maintains a capital structure with a debt-to-equity ratio of 1.07, indicating a moderate reliance on debt financing. The company's liquidity position is asse…

Dilution: Low · Liquidity: Medium
MRCPWarsaw Stock Exchange

Mercator Medical SA

Medical Equipment, Supplies & Distribution
Kurs$58.20
Børsverdi
P/E
Omsetning$130,9 mill.
Driftsresultat-$9,8 mill.
FCF$12,2 mill.

Mercator Medical maintains a strong liquidity position with a current ratio of 8.68 and $187.5 million in cash and equivalents, significantly exceeding the industry median for liquidity coverage. T…

Dilution: Low · Liquidity: Low
PGFF.PKOTC

Pgff.Pk

Healthcare Facilities & Services
Kurs$0.51
Børsverdi
P/E
Omsetning$9,3k
Driftsresultat-$390,7k
FCF-$394,3k

PGFF.PK exhibits a severely strained capital structure, with total liabilities of $1.2 billion and total equity of -$612.2 million, resulting in a negative debt-to-equity ratio of -0.98. The compan…

Dilution: Low · Liquidity: Medium
SANJBSE (India)

Sanj.Bo

Pharmaceuticals
Kurs$136.30
Børsverdi
P/E
Omsetning$701,0 mill.
Driftsresultat$97,3 mill.
FCF-$216,3 mill.

Sanj BO maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.21, indicating a low reliance on debt financing. The company's liquidity position is assessed as medi…

Dilution: Low · Liquidity: Medium
SUPMBursa Malaysia

Supermax Corporation Bhd

Medical Equipment, Supplies & Distribution
Kurs$0.32
Børsverdi
P/E
Omsetning$779,6 mill.
Driftsresultat-$190,3 mill.
FCF-$477,2 mill.

Supermax Corporation Bhd has a capital structure characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. However, the company's liquidity is rated as mediu…

Dilution: Low · Liquidity: Medium
SVEPWarsaw Stock Exchange

Svep.Wa

Pharmaceuticals
Kurs$2.75
Børsverdi
P/E
Omsetning$42,0 mill.
Driftsresultat
FCF

SVEP.WA has a debt-to-equity ratio of 0.68, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is assessed as medium, with cash and equivalents am…

Dilution: Low · Liquidity: Medium
TRIBNASDAQ

Trinity Biotech PLC

Diversified Medical Equipment & Supplies
Kurs$11.12
Børsverdi$225,2 mill.
P/E
Omsetning$43,8 mill.
Driftsresultat
FCF

Trinity Biotech operates with a negative total equity of $71.98 million and a cash and equivalents balance of $5.14 million, indicating a liquidity position that is constrained by its net cash posi…

Dilution: Low · Liquidity: Medium
TRILCBorsa Istanbul

Trilc.Is

Pharmaceuticals
Kurs$2.98
Børsverdi
P/E
Omsetning$4,54 mrd.
Driftsresultat$1,19 mrd.
FCF-$817,9 mill.

TRILC.IS has a debt-to-equity ratio of 1.57, indicating a relatively high level of leverage, and a current ratio of 1.04, suggesting limited short-term liquidity cushion. The company's free cash fl…

Dilution: Low · Liquidity: Medium
TXTM.PKOTC

Txtm.Pk

Biotechnology & Medical Research
Kurs$0.01
Børsverdi
P/E
Omsetning$640,00
Driftsresultat-$927,3k
FCF

TXTM.PK exhibits a severely negative capital structure, with total liabilities of $5.7 billion and total equity of -$5.7 billion, resulting in a debt-to-equity ratio of -0.25. The company's liquidi…

Dilution: Low · Liquidity: Medium
WINMEDMSET (Bangkok)

Winnergy Medical PCL

Medical Equipment, Supplies & Distribution
Kurs
Børsverdi
P/E
Omsetning$647,0 mill.
Driftsresultat$35,0 mill.
FCF$18,3 mill.

Winnergy Medical PCL maintains a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium risk,…

Dilution: Low · Liquidity: Medium
ZLNAOslo Børs

Zelluna ASA

Biotechnology & Medical Research
Kurskr 20.50
Børsverdikr 538,5 mill.
P/E
Omsetningkr 0,00
Driftsresultat-kr 143,8 mill.
FCF-kr 136,0 mill.

Zelluna ASA has a market capitalization of NOK 570.06 million and a price-to-book ratio of 6.64, indicating a premium valuation relative to its book value. The company's liquidity position is stron…

Dilution: Low · Liquidity: Low
000615Shenzhen Stock Exchange

Jointown Aesthetics Valley Co Ltd

Healthcare Facilities & Services
Kurs$3.55
Børsverdi
P/E
Omsetning$264,6 mill.
Driftsresultat-$36,4 mill.
FCF

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 23.18, indicating a significant reliance on debt financing. Despite a negative net income of -44.63 million CNY,…

Dilution: Low · Liquidity: Medium
002275Shenzhen Stock Exchange

Guilin Sanjin Pharmaceutical Co Ltd

Pharmaceuticals
Kurs$13.89
Børsverdi
P/E
Omsetning$2,05 mrd.
Driftsresultat$538,4 mill.
FCF$104,5 mill.

Guilin Sanjin Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 3.01, indicating the company can cover its short-term liabilities more than three times over. Howe…

Dilution: Low · Liquidity: Medium
002737Shenzhen Stock Exchange

Sunflower Pharmaceutical Group Co Ltd

Pharmaceuticals
Kurs$12.94
Børsverdi
P/E
Omsetning$2,32 mrd.
Driftsresultat-$252,4 mill.
FCF-$512,1 mill.

Sunflower Pharmaceutical Group Co Ltd has a strong liquidity position, with a current ratio of 3.04, indicating that it holds more than three times as much in current assets as it does in current l…

Dilution: Low · Liquidity: Medium
002788Shenzhen Stock Exchange

Luyan Pharma Co Ltd

Pharmaceuticals
Kurs$13.21
Børsverdi
P/E
Omsetning$5,17 mrd.
Driftsresultat$139,7 mill.
FCF

Luyan Pharma maintains a capital structure with a debt-to-equity ratio of 1.59, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a curr…

Dilution: Low · Liquidity: Medium
002923Shenzhen Stock Exchange

Zhuhai Rundu Pharmaceutical Co Ltd

Pharmaceuticals
Kurs$11.05
Børsverdi
P/E
Omsetning$291,1 mill.
Driftsresultat$10,8 mill.
FCF

Zhuhai Rundu Pharmaceutical Co Ltd maintains a debt-to-equity ratio of 0.47, indicating a relatively conservative capital structure. The company's current ratio of 1.99 suggests it has sufficient s…

Dilution: Low · Liquidity: Medium
009300KOSDAQ

009300.Kq

Pharmaceuticals
Kurs$13750.00
Børsverdi
P/E
Omsetning$77,80 mrd.
Driftsresultat$10,98 mrd.
FCF$11,09 mrd.

The company maintains a strong liquidity position, with a current ratio of 9.78, indicating that it holds significantly more current assets than current liabilities. This is supported by a free cas…

Dilution: Low · Liquidity: Medium
036480KOSDAQ

036480.Kq

Pharmaceuticals
Kurs$6510.00
Børsverdi
P/E
Omsetning$25,99 mrd.
Driftsresultat$714,3 mill.
FCF$2,50 mrd.

The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.56, indicating moderate leverage. Its liquidity position is characterized as medium, with a current r…

Dilution: Low · Liquidity: Medium
0690HKEX

0690.Hk

Pharmaceuticals
KursHK$0.09
Børsverdi
P/E
OmsetningHK$586,2 mill.
DriftsresultatHK$102,8 mill.
FCFHK$46,1 mill.

The company maintains a strong capital structure with a debt-to-equity ratio of 0.24, indicating a relatively low reliance on debt financing. Total equity stands at HKD 413.25 million, while total…

Dilution: Low · Liquidity: Medium
071200KOSDAQ

071200.Kq

Advanced Medical Equipment & Technology
Kurs$7700.00
Børsverdi
P/E
Omsetning$102,39 mrd.
Driftsresultat$14,22 mrd.
FCF$26,19 mrd.

The company maintains a strong capital structure with a debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing and a robust equity base. Its liquidity position is characterized…

Dilution: Low · Liquidity: Medium
0876HKEX

0876.Hk

Medical Equipment, Supplies & Distribution
KursHK$0.06
Børsverdi
P/E
OmsetningHK$139,1 mill.
Driftsresultat-HK$46,4 mill.
FCF

The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage position. However, the company reported a negative return on equity of -11…

Dilution: Low · Liquidity: Medium
109960KOSDAQ

109960.Kq

Pharmaceuticals
Kurs$1878.00
Børsverdi
P/E
Omsetning$9,81 mrd.
Driftsresultat-$8,81 mrd.
FCF-$5,50 mrd.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage position relative to its equity base. Despite this, the company reported n…

Dilution: Low · Liquidity: Medium
122310KOSDAQ

Genoray Co Ltd

Advanced Medical Equipment & Technology
Kurs$3510.00
Børsverdi
P/E
Omsetning$25,05 mrd.
Driftsresultat$1,70 mrd.
FCF$1,80 mrd.

Genoray maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.21, indicating a low reliance on debt financing. The company's liquidity position is characterized as…

Dilution: Low · Liquidity: Medium
1406HKEX

1406.Hk

Healthcare Facilities & Services
KursHK$0.35
Børsverdi
P/E
OmsetningHK$190,9 mill.
Driftsresultat-HK$79,9 mill.
FCF-HK$71,2 mill.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.13, indicating a conservative leverage position. It maintains a strong liquidity position with a current ratio of…

Dilution: Low · Liquidity: Low
183490KOSDAQ

183490.Kq

Pharmaceuticals
Kurs$990.00
Børsverdi
P/E
Omsetning$67,75 mrd.
Driftsresultat-$18,08 mrd.
FCF-$15,74 mrd.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position relative to its equity base. Its liquidity position is strong, wi…

Dilution: Low · Liquidity: Low
222110KOSDAQ

222110.Kq

Biotechnology & Medical Research
Kurs$4785.00
Børsverdi
P/E
Omsetning$13,42 mrd.
Driftsresultat$1,51 mrd.
FCF$2,77 mrd.

The company maintains a strong liquidity position, with a current ratio of 8.43, indicating a high ability to meet short-term obligations. Its debt-to-equity ratio is 0.03, suggesting a conservativ…

Dilution: Low · Liquidity: Low
222670.KN

222670.Kn

Pharmaceuticals
Kurs
Børsverdi
P/E
Omsetning$19,2 mill.
Driftsresultat-$1,18 mrd.
FCF-$1,36 mrd.

The company's capital structure is highly leveraged, with total liabilities of KRW 692.1 billion and total equity of -KRW 406.7 billion, resulting in a negative debt-to-equity ratio of -0.36. Liqui…

Dilution: Low · Liquidity: Medium
300149Shenzhen Stock Exchange

ChemPartner PharmaTech Co Ltd

Biotechnology & Medical Research
Kurs$9.25
Børsverdi
P/E
Omsetning$1,13 mrd.
Driftsresultat
FCF

ChemPartner maintains a debt-to-equity ratio of 0.37, indicating a relatively conservative capital structure with equity significantly outweighing liabilities. The company's liquidity position is a…

Dilution: Low · Liquidity: Medium
300326Shenzhen Stock Exchange

Shanghai Kinetic Medical Co Ltd

Medical Equipment, Supplies & Distribution
Kurs$6.79
Børsverdi
P/E
Omsetning$963,1 mill.
Driftsresultat$143,4 mill.
FCF$127,9 mill.

Shanghai Kinetic Medical Co Ltd maintains a strong liquidity position, with a current ratio of 12.47, indicating that it holds significantly more current assets than current liabilities. The compan…

Dilution: Low · Liquidity: Medium
300642Shenzhen Stock Exchange

Tellgen Corp

Medical Equipment, Supplies & Distribution
Kurs$14.54
Børsverdi$2,36 mrd.
P/E658,7
Omsetning$363,8 mill.
Driftsresultat-$2,8 mill.
FCF-$36,0 mill.

Tellgen Corp maintains a capital structure with a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position compared to industry norms. The company's liquidity is assesse…

Dilution: Low · Liquidity: Medium
300966Shenzhen Stock Exchange

300966.Sz

Pharmaceuticals
Kurs$27.10
Børsverdi
P/E
Omsetning$606,2 mill.
Driftsresultat-$104,8 mill.
FCF-$163,0 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 1.59, indicating a relatively high level of leverage. Liquidity is assessed as medium, with a current ratio of 0.94, su…

Dilution: Low · Liquidity: Medium
301580Shenzhen Stock Exchange

Aidite Qinhuangdao Technology Co Ltd

Medical Equipment, Supplies & Distribution
Kurs$61.36
Børsverdi
P/E
Omsetning$1,03 mrd.
Driftsresultat$215,4 mill.
FCF$118,3 mill.

Aidite Qinhuangdao Technology Co Ltd maintains a strong liquidity position, with a current ratio of 8.14, indicating that it holds significantly more current assets than current liabilities. The co…

Dilution: Low · Liquidity: Medium
3681HKEX

3681.Hk

Pharmaceuticals
KursHK$1.22
Børsverdi
P/E
OmsetningHK$0,00
Driftsresultat-HK$99,5 mill.
FCF

The company's capital structure is characterized by a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing. It holds CNY 322.7 million in cash and equivalents, but this is…

Dilution: Low · Liquidity: Medium
378800KOSDAQ

378800.Kq

Biotechnology & Medical Research
Kurs$1349.00
Børsverdi$62,38 mrd.
P/E
Omsetning$227,8 mill.
Driftsresultat-$15,61 mrd.
FCF-$14,76 mrd.

The company maintains a strong liquidity position, as evidenced by a current ratio of 12.53, indicating a significant excess of current assets over current liabilities. The price-to-book ratio of 2…

Dilution: Low · Liquidity: Low
4188TPEx

4188.Two

Advanced Medical Equipment & Technology
Kurs$11.55
Børsverdi
P/E
Omsetning$30,4 mill.
Driftsresultat-$87,9 mill.
FCF-$56,7 mill.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. It holds significant liquidity with a current ratio of 22.62, su…

Dilution: Low · Liquidity: Low
4197TPEx

4197.Two

Medical Equipment, Supplies & Distribution
Kurs$9.70
Børsverdi
P/E
Omsetning$179,1 mill.
Driftsresultat
FCF

4197.TWO maintains a debt-to-equity ratio of 0.48, indicating a relatively conservative capital structure with equity significantly outweighing debt. The company holds cash and equivalents of TWD 6…

Dilution: Low · Liquidity: Medium
456570.KN

456570.Kn

Biotechnology & Medical Research
Kurs$13140.00
Børsverdi
P/E
Omsetning$0,00
Driftsresultat-$5,62 mrd.
FCF-$39,78 mrd.

The company's capital structure is highly leveraged, with total liabilities of KRW 7.5 trillion and total equity of -KRW 6.0 trillion, resulting in a negative debt-to-equity ratio of -0.31. Despite…

Dilution: Low · Liquidity: Medium
4884Tokyo Stock Exchange

Kringle Pharma Inc

Biotechnology & Medical Research
Kurs¥293.00
Børsverdi
P/E
Omsetning¥24,3 mill.
Driftsresultat-¥198,2 mill.
FCF

Kringle Pharma Inc has a highly liquid capital structure, with cash and equivalents amounting to ¥2,489,564,000, which significantly exceeds its total liabilities of ¥589,756,000, resulting in a cu…

Dilution: Low · Liquidity: Low
489460KOSDAQ

489460.Kq

Pharmaceuticals
Kurs$7040.00
Børsverdi$105,91 mrd.
P/E24,2
Omsetning$28,49 mrd.
Driftsresultat$4,23 mrd.
FCF$4,14 mrd.

The company maintains a strong liquidity position, with a current ratio of 30.2 and cash and equivalents amounting to KRW 11,641,966,830. The debt-to-equity ratio is 0.01, indicating a low reliance…

Dilution: Low · Liquidity: Low
6549TPEx

6549.Two

Biotechnology & Medical Research
Kurs$8.00
Børsverdi$641,0 mill.
P/E
Omsetning$0,00
Driftsresultat-$25,2 mill.
FCF-$23,0 mill.

The company's capital structure is characterized by a high proportion of equity, with total equity of 70,923,000 TWD and total liabilities of 6,325,000 TWD, resulting in a debt-to-equity ratio of 0…

Dilution: Low · Liquidity: Low
6634TPEx

6634.Two

Biotechnology & Medical Research
Kurs$64.00
Børsverdi
P/E
Omsetning$47,0k
Driftsresultat-$140,1 mill.
FCF-$106,3 mill.

The company exhibits a highly leveraged equity structure, with a debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing. However, the company's liquidity position is characteri…

Dilution: Low · Liquidity: Medium
6678Tokyo Stock Exchange

6678.T

Medical Equipment, Supplies & Distribution
Kurs¥2009.00
Børsverdi¥13,39 mrd.
P/E13,1
Omsetning¥9,91 mrd.
Driftsresultat¥1,32 mrd.
FCF¥602,5 mill.

The company maintains a strong liquidity position, with cash and equivalents amounting to ¥9,061,387,000, representing a significant portion of its total assets. The liquidity FPT (free cash flow t…

Dilution: Low · Liquidity: Low
6931TWSE

6931.Tw

Healthcare Facilities & Services
Kurs$40.60
Børsverdi
P/E
Omsetning$1,12 mrd.
Driftsresultat$57,0 mill.
FCF$103,2 mill.

The company's capital structure is characterized by a debt-to-equity ratio of 1.05, indicating a moderate level of leverage. Its liquidity position is marked by a current ratio of 3.93, suggesting…

Dilution: Low · Liquidity: Medium
6932TPEx

6932.Two

Pharmaceuticals
Kurs$7.79
Børsverdi
P/E
Omsetning$0,00
Driftsresultat-$68,4 mill.
FCF-$62,9 mill.

The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.19, indicating a conservative leverage position. However, the company reported a negative return on eq…

Dilution: Low · Liquidity: Medium
6936TWSE

Vetnostrum Animal Health Co Ltd

Pharmaceuticals
Kurs$33.30
Børsverdi
P/E
Omsetning$280,0 mill.
Driftsresultat$33,5 mill.
FCF$40,6 mill.

Vetnostrum maintains a conservative capital structure with a low debt-to-equity ratio of 0.07, indicating minimal reliance on debt financing. The company's liquidity position is characterized as me…

Dilution: Low · Liquidity: Medium